Valuation : Panacea Life Sciences Holdings, Inc.

Market Cap 5L 4L 4L 4L 7L 4.96Cr 7L 49.75L 19.41L 2.5Cr 19.49L 19.06L 8.3Cr P/E 2022
-0.11x
P/E 2023 -0.31x
Enterprise Value 2.2Cr 1.9Cr 1.78Cr 1.63Cr 3.06Cr 210.73Cr 3.07Cr 21Cr 8.25Cr 106.37Cr 8.28Cr 8.1Cr 352.72Cr EV / Sales 2022
11.6x
EV / Sales 2023 10.1x
Free-Float
18.65%
Yield 2022 *
-
Yield 2023 -
18/11 Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH CI
06/24/06 Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
01/24/01 Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
01/24/01 Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
15/23/15 Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
05/23/05 Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc. CI
02/23/02 Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc. CI
30/23/30 Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million. CI
15/23/15 Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
02/23/02 Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million. CI
10/23/10 Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom. CI
10/23/10 Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida. CI
15/23/15 Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K CI
1 day+7.02%
1 week+7.02%
Current month+6.94%
1 month+9.78%
3 months+182.29%
6 months+140.98%
Current year+97.60%
1 week 0.09
Extreme 0.09
0.1
1 month 0.08
Extreme 0.0762
0.1
Current year 0.02
Extreme 0.0211
0.14
1 year 0.02
Extreme 0.0211
0.2
3 years 0.02
Extreme 0.0211
0.36
5 years 0.02
Extreme 0.0211
3.33
10 years 0.02
Extreme 0.0211
5.57
Manager TitleAgeSince
Chief Executive Officer 69 30/06/2021
President - -
Chief Tech/Sci/R&D Officer 61 01/01/2017
Director TitleAgeSince
Chairman 69 30/06/2021
Director/Board Member 68 29/04/2020
Date Insider Type Main position Quantity % Market Cap.
18/09/23 Buy

Chief Executive Officer

20,000 0.1133%
02/06/23 Free

Chief Executive Officer

7,63,000 4.9209%
19/05/23 Other

Chief Executive Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+7.02%+7.02%+95.64%-52.27% 58.76L
-0.13%-6.44%+60.47%+112.05% 1,04700Cr
+0.85%-0.81%+52.77%+63.15% 65TCr
-1.03%-3.58%+22.87%+73.29% 45TCr
-1.46%-4.50%+37.43%+38.41% 35TCr
-0.72%-2.89%+21.86%+36.79% 29TCr
-1.19%-2.21%+1.35%+12.29% 25TCr
-1.05%-1.57%+51.40%+68.55% 23TCr
+0.08%-1.78%-17.64%-54.29% 20TCr
-2.14%-0.30%+29.42%+89.10% 18TCr
Average +0.01%-1.71%+35.56%+38.71% 36.59TCr
Weighted average by Cap. -0.48%-3.46%+38.66%+65.51%

Financials

2022 2023
Net sales 16.27L 14.02L 13.14L 12L 22.6L 16Cr 22.68L 1.56Cr 60.85L 7.85Cr 61.08L 59.76L 26Cr 23.85L 20.55L 19.27L 17.59L 33.14L 23Cr 33.24L 2.29Cr 89.19L 12Cr 89.54L 87.59L 38Cr
Net income -91.43L -78.78L -73.87L -67.43L -1.27Cr -87Cr -1.27Cr -8.76Cr -3.42Cr -44Cr -3.43Cr -3.36Cr -146.26Cr -80.15L -69.07L -64.76L -59.11L -1.11Cr -77Cr -1.12Cr -7.68Cr -3Cr -39Cr -3.01Cr -2.94Cr -128.22Cr
Net Debt 1.79Cr 1.54Cr 1.44Cr 1.32Cr 2.48Cr 170.63Cr 2.49Cr 17Cr 6.68Cr 86Cr 6.7Cr 6.56Cr 285.61Cr 2.15Cr 1.86Cr 1.74Cr 1.59Cr 2.99Cr 205.77Cr 3Cr 21Cr 8.05Cr 103.87Cr 8.08Cr 7.91Cr 344.41Cr
Logo Panacea Life Sciences Holdings, Inc.
Panacea Life Sciences Holdings, Inc. is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, research, and distribution of products within natural health and wellness market segment for both humans and animals. The Company's subsidiary, Panacea Life Sciences, Inc., is dedicated to the distribution of nutraceuticals, cannabinoids and other natural, plant-based ingredients and products. The Company offers pure natural remedies within various product lines: PANA Life, PANA Beauty, PANA Sport, PANA Pet and PANA Health. It sells over 40 different product SKUs of CBD and CBG products. Its products are formulated with delivery methods for health benefits including an intellectual property portfolio enabling development of topical creams, sublinguals, oral soft gel capsules, patches, and sprays. Its Benivita PLSH provides access to non-insurance benefits, virtual telemedicine services, and lifestyle wellness programs.
Employees
40
Date Price Change Volume
28/26/28 $0.0988 +7.02% 13,490
  1. Stock Market
  2. Stocks
  3. PLSH Stock